Funded Tech Companies
Bolt Biotherapeutics
Headquartered in Redwood City, Bolt Biotherapeutics is venture-backed, with investment from Pfizer Venture Investments, Novo Ventures and Vivo Capital.
Company Overview
Company Name
Bolt Biotherapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
640 Galveston Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Company Background Information
Overview
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a private biotechnology company developing Boltbody Immune-stimulating Antibody Conjugates (ISAC), a new class of cancer therapeutics. These systemically-administered, tumor-targeted Boltbody therapeutics unleash the immune system to induce anti-tumor immunity.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/5/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Peter Moldt
Chief Executive Officer
Randall Schatzman
Chief Financial Officer
William Quinn
Chief Medical Officer
Edith Perez
Vice President
Michael Alonso
Vice President
Nathan Ihle
Vice President
Marcin Kowanetz
Vice President
Brian Safina
VP - Bus. Development
Grant Yonehiro
VP - Engineering
Karla Henning
VP - Manufacturing
Travis Tani
VP - R & D
David Dornan
Company Investors
- Pfizer Venture Investments
- Novo Ventures (Peter Moldt)
- Vivo Capital
- Pivotal bioVenture Partners (Ash Khanna)
- Rock Springs Capital
- Samsara BioCapital
- Sofinnova Ventures (Jason Pitts)
- RA Capital
- Surveyor Capital
- Nan Fung Life Sciences
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs